Malignant brain tumors: Benefit of PET and PET/CT in the detection of recurrences is not assessable
Missing studies could be conducted within a reasonable amount of time through international cooperation
2011-01-20
(Press-News.org) Malignant gliomas are fast-growing brain tumours with poor prospects of recovery depending on disease stage. Experts hope that the examination of patients by means of positron emission tomography (PET) is more helpful in the choice of the right treatment than other procedures. In a final report the German Institute for Quality and Efficiency in Health Care (IQWiG) has now investigated the benefit of PET in the detection of recurrences. According to this report, no robust conclusions are possible on the advantages or disadvantages of PET.
Two research questions investigated
The Institute investigated two research questions:
First question: Does PET as a single device or as a combination of PET and computer tomography (CT) in one device (PET/CT) contribute to patients with recurrence of glioma surviving longer or experiencing fewer complications caused by their disease or treatment? This question could not be answered by IQWiG, as no robust study was found in the literature allowing any conclusions on the patient-relevant (additional) benefit of this intervention.
The Institute also investigated a second question: Can recurrence of glioma after treatment be detected more accurately with PET or PET/CT than with other methods? Twelve studies on PET conducted over a period of two decades were identified; however, the results for this procedure differed so substantially between studies that no general answer could be provided. Not a single study on PET/CT was found.
This lack of good studies is regrettable. PET has been applied in studies investigating patients with brain tumours since the early eighties; there would have been enough time to conduct meaningful studies. IQWiG therefore advocates that these missing studies be conducted as quickly as possible. As gliomas are relatively rare, ideally several hospitals should cooperate on an international level in order to obtain robust data within a reasonable period of time.
How does PET work?
CT and magnetic resonance imaging (MRI), also referred to as magnet resonance tomography (MRT), are procedures used to diagnose brain tumours. These devices can depict whole organs in a three-dimensional manner. If a patient with a brain tumour is treated with radiotherapy, it is often not possible to distinguish on images of the brain whether the visible residuals represent active cancer tissue or tissue residuals destroyed by radiation (radiation necroses).
PET is supposed to help solve this problem. For this purpose, patients are injected a contrast agent that emits weak and non-toxic radiation. As tumour tissue often has a more active metabolism than healthy or necrotic tissue, the radioactive contrast agent accumulates there. This "illuminating" tissue in the body can be measured by means of PET and blended into CT images, so that doctors can see the location and metabolic activity of any tissue abnormalities at the same time. In newer studies, PET and MRI are also combined.
Even if the PET examination provided more information, this would not necessarily mean that patients would benefit from it. The decisive question is whether PET or PET/CT improves the treatment of patients by, for example, helping doctors choose the best treatment for the individual patient.
INFORMATION:
Procedure of report production
IQWiG published the preliminary results in the form of the preliminary report in July 2010 and interested parties were invited to submit comments. When the comments stage ended, the preliminary report was revised and sent as a final report to the contracting agency, the Federal Joint Committee, in November 2010. The written comments are published in a separate document at the same time as the final report. The report was produced in collaboration with external experts.
END
ELSE PRESS RELEASES FROM THIS DATE:
2011-01-20
Recent work, in particular the CAMERA study, has used MRI to study the brains of migraine sufferers and has shown that a higher proportion of these patients exhibit lesions of the brain microvessels than the rest of the population.
Lesions of the brain microvessels
Lesions of the brain microvessels, visible on cerebral MRI images, can be of various kinds: white-matter hyperintensities and, more rarely, silent infarcts leading to loss of white-matter tissue.
They result from a deterioration of the small cerebral arteries that supply blood to the brain's white matter, ...
2011-01-20
Fairfax, Va., January 18, 2011 – HIV-positive head and neck cancer patients respond well to radiation therapy treatments and experience similar toxicity rates as non-HIV-positive patients, despite prior reports to the contrary, according to a study in the January issue of the International Journal of Radiation Oncology•Biology•Physics, an official journal of the American Society for Radiation Oncology (ASTRO).
Patients with HIV have a significantly higher risk of developing some types of cancers; however, since the use of highly active antiretroviral therapy (HAART) began ...
2011-01-20
In birds as in humans, female fertility declines with age.
But some female birds can slow the ticking of their biological clocks by choosing the right mates, according to results of a study published online last week in the journal Oikos.
Female birds become progressively less fertile as age takes its toll, says biologist Josh Auld of the National Evolutionary Synthesis Center in Durham, North Carolina, and co-author of the Oikos paper.
Older females lay fewer eggs, and they lay them later in the season--at a time when less food is available for their chicks.
But ...
2011-01-20
DETROIT— The combined results of a genetic blood test and a five-minute functional MRI successfully classified more than three-quarters of healthy older adults, many of whom were destined to develop cognitive decline within 18 months of testing.
John Woodard, Ph.D., associate professor of psychology in the College of Liberal Arts and Sciences and Institute of Gerontology at Wayne State University, is lead author of "Predicting Cognitive Decline in Healthy Older Adults Using fMRI" published in the Journal of Alzheimer's Disease (vol. 21, no. 3).
"No one had studied ...
2011-01-20
CAMBRIDGE, Mass. -- MIT scientists have discovered that cells lining the blood vessels secrete molecules that suppress tumor growth and keep cancer cells from invading other tissues, a finding that could lead to a new way to treat cancer.
Elazer Edelman, professor in the MIT-Harvard Division of Health Sciences and Technology (HST), says that implanting such cells adjacent to a patient's tumor could shrink a tumor or prevent it from growing back or spreading further after surgery or chemotherapy. He has already tested such an implant in mice, and MIT has licensed the technology ...
2011-01-20
Baked goods made from hydrolyzed wheat flour are not toxic to celiac disease patients, according to a new study in Clinical Gastroenterology and Hepatology, the official journal of the American Gastroenterological Association (AGA) Institute. Celiac disease occurs in the digestive system when people cannot tolerate a protein called gluten, which is found primarily in wheat.
"This is the first time that a wheat flour-derived product is shown to not be toxic after being given to celiac patients for 60 days," said Luigi Greco, MD, PhD, of the University of Napes, Italy, ...
2011-01-20
Montreal, January 19, 2011 – Toddlers who learn a second language from infancy have an edge over their unilingual peers, according to a new study from Concordia University and York University in Canada and the Université de Provence in France. As reported in the Journal of Experimental Child Psychology, the research team tested the understanding of English and French words among 24-month-olds to see if bilingual toddlers had acquired comparable vocabulary in each language.
"By 24 months, we found bilingual children had already acquired a vocabulary in each of their two ...
2011-01-20
CHAPEL HILL, N.C. – Scientists around the world have been hot on the trail of a genetic mutation closely associated with some brain cancers and leukemia since the mutation's discovery in 2008. The hunt is now yielding fruit. In the Jan. 18, 2011 issue of Cancer Cell, researchers reveal how the mutation contributes to cancer development and suggest potential ways to counter its effects.
About 75 percent of people with low-grade brain tumors and 20 percent of people with acute myeloid leukemia have a mutated version of a gene known as IDH. IDH helps cells metabolize, or ...
2011-01-20
PITTSBURGH, Jan. 18 – Family caregivers who had not discussed life support measures with critically ill patients took nearly two weeks longer to decide to forego further medical intervention than those who had prior conversations about the issues, according to researchers from the University of Pittsburgh School of Medicine and the Graduate School of Public Health. They share their findings in a poster presentation at the Society of Critical Care Medicine congress this week in San Diego.
Also, a patient's loved ones were more confident about acting as surrogate decision-makers ...
2011-01-20
Washington, DC, January 19, 2011— Both boys and girls who are victims of bullying, including bullying through e-mail and the internet, are at elevated risk for depression. However, according to a new study, adolescent girls may engage in substance use as a result of bullying-related depression,.
As schools reopen following the holidays, the message to parents of adolescent girls is that bullying can have serious consequences:"If your daughter is a victim of bullying, take it seriously, do all possible to prevent recurrence, and attend to possible depression and substance ...
LAST 30 PRESS RELEASES:
[Press-News.org] Malignant brain tumors: Benefit of PET and PET/CT in the detection of recurrences is not assessable
Missing studies could be conducted within a reasonable amount of time through international cooperation
